HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Raspagliesi Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

1/2021Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study.
10/2020Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study.
10/2016Is aortic lymphadenectomy indicated in locally advanced cervical cancer after neoadjuvant chemotherapy followed by radical surgery? A retrospective study on 261 women.
8/2015How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy?
7/2014Class II versus Class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center.
3/2013Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study.
1/2002Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Raspagliesi Research Topics

Disease

12Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 05/2001
10Neoplasms (Cancer)
01/2022 - 12/2001
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 01/2002
7Carcinoma (Carcinomatosis)
03/2013 - 05/2001
5Ovarian Epithelial Carcinoma
01/2022 - 05/2001
2Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 11/2015
2Pain (Aches)
01/2018 - 11/2006
1Peripheral Nervous System Diseases (PNS Diseases)
01/2018
1Ascites
11/2017
1Neoplasm Metastasis (Metastasis)
10/2016
1Disease Progression
01/2016
1Lymphatic Metastasis
03/2013
1Margins of Excision
08/2011
1Bowen's Disease (Disease, Bowen)
11/2006
1Basal Cell Carcinoma (Rodent Ulcer)
11/2006
1Edema (Dropsy)
11/2006
1Type 2 Diabetes Mellitus (MODY)
09/2005
1Sarcoma (Soft Tissue Sarcoma)
11/2004
1Vulvar Neoplasms (Vulvar Cancer)
05/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2002
1Dysgerminoma
12/2001
1Granulosa Cell Tumor
12/2001
1Testicular Neoplasms (Testicular Cancer)
12/2001
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2001
1Carcinogenesis
12/2001
1Residual Neoplasm
05/2001

Drug/Important Bio-Agent (IBA)

4PlatinumIBA
01/2018 - 01/2006
3Paclitaxel (Taxol)FDA LinkGeneric
01/2016 - 01/2002
2Monoclonal AntibodiesIBA
01/2022 - 01/2022
2EpitopesIBA
01/2022 - 01/2022
2Mucin-1 (CA 15-3 Antigen)IBA
01/2022 - 01/2022
2TrabectedinIBA
11/2017 - 03/2016
2Cisplatin (Platino)FDA LinkGeneric
03/2013 - 05/2001
1ErbB Receptors (EGF Receptor)IBA
01/2022
1CarbohydratesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Bevacizumab (Avastin)FDA Link
10/2020
1pembrolizumabIBA
01/2019
1Glycoproteins (Glycoprotein)IBA
11/2017
1Orosomucoid (Seromucoid)IBA
11/2017
1PM 01183IBA
11/2017
1Proteins (Proteins, Gene)FDA Link
11/2017
1trebananibIBA
01/2016
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2015
1Topotecan (Hycamtin)FDA LinkGeneric
03/2013
1AcidsIBA
11/2006
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2006
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2006
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2006
1liposomal doxorubicin (Doxil)FDA Link
01/2006
1Blood Glucose (Blood Sugar)IBA
09/2005
1Glucose (Dextrose)FDA LinkGeneric
09/2005
1SolutionsIBA
05/2003
1Coloring Agents (Dyes)IBA
05/2003
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2003
1Inhibins (Inhibin)IBA
12/2001
1Tumor Biomarkers (Tumor Markers)IBA
12/2001
1Activins (Activin)IBA
12/2001
1Mitomycin (Mitomycin-C)FDA LinkGeneric
05/2001

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2022 - 08/2006
5Hysterectomy
01/2021 - 08/2011
5Cytoreduction Surgical Procedures
07/2014 - 05/2001
4Therapeutics
01/2022 - 01/2005
3Radiotherapy
01/2022 - 01/2002
2Lymph Node Excision (Lymph Node Dissection)
10/2016 - 05/2003
2Neoadjuvant Therapy
10/2016 - 08/2015
2Adjuvant Chemotherapy
03/2013 - 01/2012
1Photochemotherapy (Photodynamic Therapy)
11/2006
1Combination Drug Therapy (Combination Chemotherapy)
01/2006
1Salvage Therapy
05/2001